Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #173

    Can epcoritamab reshape salvage DLBCL care? Genmab’s Phase 3 data brings regulatory momentum https://pharmadevicenews.com/can-epcoritamab-reshape-salvage-dlbcl-care-genmabs-phase-3-data-brings-regulatory-momentum/

    1 Reply Last reply
    0
    • N Offline
      N Offline
      NiklasZ
      wrote on sidst redigeret af
      #174

      @EL Do not mention Grok... you risk awakening the trolls from the Tesla ch
      at. 😄

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #175

        Godmorgen 🙂

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #176

          lol, i'll say Perplexity next time 😉 . I try to Buy European given the current political climate, but unfortunately we are dangerously behind here on these things...

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #177

            just to put friday's price action into perspective; expert Hutchings compares the data to STARGLO https://x.com/DocHutchings/status/2012577901636362506 , which is Glofitamab plus chemo, while the epco DLBCL-1 data is monotherapy and has a different population. i really don't think you can do that

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #178

              if even experts like him make these mistakes, just think about the average investor...

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #179

                (and by the way, tomorrow is a US holiday, Martin Luther King day, which presumably will have impacted volume on this late friday news)

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #180

                  Teclistamab Monotherapy Improves OS and PFS Over SOC in Relapsed/Refractory Multiple Myeloma -reducing disease progression or death risk by 71% and death risk by 40%. -the Independent Data Monitoring Committee recommended unblinding the trial based on the strength of the results.
                  https://www.onclive.com/view/teclistamab-monotherapy-improves-os-and-pfs-over-soc-in-relapsed-refractory-multiple-myeloma

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #181

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #182

                      Genmab viser igen gode takter med kræftmiddel i fase 3-studie https://proinvestor.com/investornyt/1404446/genmab-viser-igen-gode-takter-med-kraeftmiddel-i-fase-3-studie

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Stroka
                        wrote on sidst redigeret af
                        #183

                        God morgen. 🙂

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #184

                          How AbbVie’s epcoritamab reshapes the competitive calculus in relapsed diffuse large B-cell lymphoma https://pharmadevicenews.com/how-abbvies-epcoritamab-reshapes-the-competitive-calculus-in-relapsed-diffuse-large-b-cell-lymphoma/

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #185

                            this article addresses a lot of the points mentioned here

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #186

                              Matt Phipps
                              William Blair
                              Buy Reiterated https://longbridge.com/en/news/272881086?channel=WHAB0002

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #187

                                and https://www.tipranks.com/news/ratings/genmab-limited-epkinly-approval-risk-and-high-value-2026-pipeline-catalysts-support-buy-rating-ratings

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #188

                                  James Gordon CFA
                                  Barclays
                                  Buy Kr.2,500.00 Maintained Today

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #189

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      KWC
                                      wrote on sidst redigeret af
                                      #190

                                      Nogen der kan se handel ?

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #191

                                        Vi er ned med 4-5%

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          KWC
                                          wrote on sidst redigeret af
                                          #192

                                          Der kom den 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper